Brain-derived neurotrophic factor in patients with frontotemporal dementia
- PMID: 10670781
- DOI: 10.1016/s0304-3940(99)00937-4
Brain-derived neurotrophic factor in patients with frontotemporal dementia
Abstract
Brain-derived neurotrophic factor (BDNF) promotes survival and growth of various nerve cell populations during normal development and following different insults in the developing and adult brain. BDNF expression is reduced in Alzheimer disease, but little is known about BDNF expression in other types of dementia. Frontotemporal dementia (FTD) is a common cause of mental impairment in old age, which is characterized by neuron loss in the upper cortical layers mainly of the frontal and temporal cortex. BDNF protein expression has been examined by Western blotting and immunohistochemistry in the cerebral cortex of individuals affected by FTD. Examination of pathological samples (n = 8, mean age: 74.7 years; four men, four women) was conducted in parallel with corresponding samples from age-matched controls (n = 8; mean age: 72.6 years; three men, five women). Post-mortem delay was between 2 and 6 h. Preserved BDNF expression, as revealed by Western blotting, has been observed in the frontal and temporal cortices of patients with FTD. Furthermore, immunohistochemistry has disclosed maintained BDNF immunoreactivity in surviving neurons of the upper cellular layers, as well as in neurons of the inner cellular layers in FTD. These results show that FTD is not associated with a decay of BDNF in cortical neurons, and therefore, that BDNF is differentially regulated in diseases causing dementia.
Similar articles
-
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.Acta Neuropathol. 2001 Mar;101(3):256-70. doi: 10.1007/s004010000293. Acta Neuropathol. 2001. PMID: 11307626
-
[Frontotemporal dementias].Neurol Neurochir Pol. 2000 May-Jun;34(3):553-64. Neurol Neurochir Pol. 2000. PMID: 10979548 Review. Polish.
-
Neurons and their dendrites in frontotemporal dementia.Dement Geriatr Cogn Disord. 1999;10 Suppl 1:55-60. doi: 10.1159/000051214. Dement Geriatr Cogn Disord. 1999. PMID: 10436342 Review.
-
Proton magnetic resonance spectroscopy in frontotemporal dementia.J Neurol. 2006 Jul;253(7):861-8. doi: 10.1007/s00415-006-0045-y. Epub 2006 Jul 17. J Neurol. 2006. PMID: 16845570
-
Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.Neurobiol Aging. 2004 Sep;25(8):1051-6. doi: 10.1016/j.neurobiolaging.2003.10.007. Neurobiol Aging. 2004. PMID: 15212830
Cited by
-
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):851-858. doi: 10.1136/jnnp-2017-317492. Epub 2018 Feb 6. J Neurol Neurosurg Psychiatry. 2018. PMID: 29434051 Free PMC article.
-
Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.J Neurosci. 2004 Mar 3;24(9):2270-6. doi: 10.1523/JNEUROSCI.1658-03.2004. J Neurosci. 2004. PMID: 14999077 Free PMC article.
-
Serum brain-derived neurotrophic factor levels in different neurological diseases.Biomed Res Int. 2013;2013:901082. doi: 10.1155/2013/901082. Epub 2013 Aug 19. Biomed Res Int. 2013. PMID: 24024214 Free PMC article.
-
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran.Neurol Sci. 2016 Jun;37(6):935-42. doi: 10.1007/s10072-016-2520-2. Epub 2016 Apr 12. Neurol Sci. 2016. PMID: 27071687
-
Examination of Akt and GSK3β in BDNF-mediated reductions in BACE1 activity in neuronal cells.Physiol Rep. 2024 Aug;12(16):e70001. doi: 10.14814/phy2.70001. Physiol Rep. 2024. PMID: 39161054 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical